HALO THERAPEUTICS LTD
Company number 13079698 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£2,003,798
Balance sheet as at 2023-12-31
What it does
The principal activity of the company is research and experimental development on biotechnology.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-12-14
- Employees
- 3 (2024 accounts · was 1 in 2023)
- Registered office
- Ty Merlin Caerphilly Business Park, Van Road, Caerphilly, Wales, CF83 3GS
- Postcode
- CF83 3GS
- Capital
- 223 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-10-30
- Next due by
- 2026-11-13
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 3 resigned
Contact details
- Website
- halo-therapeutics.com
- Phone
- +44 7907208697
Breakthrough Therapeutics, Engineered with Intention. We leverage leading-edge technologies to create highly targeted small molecule treatments.
Among its peers
Top 25%
by shareholders' funds, of 36 similar companies in CF
Trading since 2020.
No.5 of the largest research and experimental development on biotechnology companies in Cardiff →
Competitors Cardiff
This company ranks 5 among research and experimental development on biotechnology in Cardiff.
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.